GO:0016303 1-phosphatidylinositol-3-kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016303 describes the catalytic activity that transfers the gamma-phosphate of ATP to the D-3 position of the inositol ring of phosphatidylinositol, producing phosphatidylinositol 3-phosphate (PI3P) and ADP.
• This activity is carried out by phosphoinositide 3-kinases (PI3Ks), which are grouped into classes I, II, and III based on structure and substrate specificity.
• PI3K signaling is central to cell growth, survival, metabolism, and autophagy, and its dysregulation is a hallmark of many cancers.
• Class III PI3K (Vps34) is essential for autophagy initiation and endosomal trafficking, and it also regulates hepatic glucocorticoid receptor stability.
• Class II PI3K C2α has a unique structural architecture that determines its membrane binding and catalytic output.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect the specific roles of PI3K isoforms in health and disease.
Description
1-phosphatidylinositol-3-kinase activity (GO:0016303) is a molecular function that catalyzes the phosphorylation of phosphatidylinositol at the 3-hydroxyl group of the inositol ring, generating phosphatidylinositol 3-phosphate (PI3P) and other 3-phosphoinositides. This reaction is the first committed step in the phosphoinositide 3-kinase (PI3K) signaling pathway, which controls diverse cellular processes including proliferation, survival, migration, and autophagy. The enzymes responsible, PI3Ks, are classified into three classes (I, II, and III) based on their domain structure and substrate preference. Because PI3K signaling is frequently hijacked in human diseases such as cancer, understanding the precise regulation and function of each PI3K isoform is a major research focus. Researchers study GO:0016303 to uncover how cells interpret extracellular cues and how mutations in PI3K genes or upstream regulators contribute to disease. For example, noncanonical PI3Kγ signaling has been shown to drive leukemia dependency, highlighting the therapeutic potential of targeting this activity. In gastric cancer, the PI3K/AKT/mTOR axis is a central node for targeted therapy. Beyond cancer, PI3K activity is critical for autophagy initiation, where class III PI3K (Vps34) generates PI3P to recruit autophagic machinery. It also plays a role in metabolic regulation, as class III PI3K promotes hepatic glucocorticoid receptor stability and transcriptional activity. Thus, GO:0016303 is not only a fundamental enzymatic activity but also a hub for disease mechanisms and drug discovery. This article provides a comprehensive overview of the definition, mechanism, key genes, regulation, disease relevance, and research methods for GO:0016303, with a focus on how CRISPR-based models can accelerate discoveries in this field.
1-phosphatidylinositol-3-kinase activity At A Glance
| GO ID | GO:0016303 |
|---|---|
| GO term | 1-phosphatidylinositol-3-kinase activity |
| Ontology | molecular_function |
| Synonym | PI3K activity; phosphatidylinositol 3-kinase activity; PtdIns-3-kinase activity; type III phosphoinositide 3-kinase activity; class I phosphatidylinositol 3-kinase activity; class II phosphatidylinositol 3-kinase activity; class III phosphatidylinositol 3-kinase activity |
| Definition | Catalysis of the reaction: a 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + H+. |
| Major function | Phosphorylation of phosphatidylinositol at the D-3 position to generate phosphatidylinositol 3-phosphate and other 3-phosphoinositides, which act as second messengers in signal transduction, membrane trafficking, and autophagy. |
| EC number | 2.7.1.137 |
| Related pathways | PI3K/AKT/mTOR signaling; autophagy; endocytosis; insulin signaling. |
What Is GO:0016303?
According to the Gene Ontology, GO:0016303 (1-phosphatidylinositol-3-kinase activity) is defined as the catalysis of the reaction: a 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + H+. In simpler terms, it is the enzyme activity that adds a phosphate group to the third position of the inositol ring of phosphatidylinositol, using ATP as the phosphate donor. This activity is synonymous with phosphatidylinositol 3-kinase activity and is mediated by enzymes known as PI3Ks, which include class I, class II, and class III isoforms.
Why Is 1-phosphatidylinositol-3-kinase activity Important in Cell Biology?
GO:0016303 is fundamentally important because it initiates the PI3K signaling cascade, which regulates cell growth, survival, metabolism, and autophagy. Dysregulation of this activity is implicated in a wide range of human diseases, especially cancer, where mutations in PI3K genes or upstream regulators lead to constitutive pathway activation. For instance, noncanonical PI3Kγ signaling supports leukemia cell survival, and targeting this activity has emerged as a therapeutic strategy. In gastric cancer, the PI3K/AKT/mTOR pathway is a major driver and a focus of drug development. Beyond cancer, class III PI3K is essential for autophagy, a process critical for cellular homeostasis and defense against neurodegeneration. Additionally, PI3K activity influences metabolic and endocrine functions, such as hepatic glucocorticoid receptor stability. Therefore, understanding GO:0016303 is key to deciphering normal physiology and developing treatments for multiple diseases.
• Central to cell growth and survival signaling through the PI3K/AKT/mTOR pathway.
• Frequently mutated or hyperactivated in human cancers, making it a prime drug target.
• Essential for autophagy initiation via class III PI3K (Vps34) and PI3P generation.
• Regulates membrane trafficking and endosomal sorting.
• Involved in metabolic control, including insulin signaling and glucocorticoid receptor function.
• Plays a role in muscle atrophy and exercise-induced adaptations through IGF-1/IGF-1R-PI3K/Akt signaling.
• Contributes to stemness and tumorigenicity in colorectal cancer.
• Provides a mechanistic link between extracellular cues and transcriptional programs.
• Targeted by small-molecule inhibitors and biologics in clinical trials for cancer and other diseases.
• Its structural and regulatory complexity offers opportunities for isoform-selective drug design.
What Happens During 1-phosphatidylinositol-3-kinase activity?
Substrate binding and membrane recruitment
In simple terms: The enzyme attaches to the cell membrane and grabs its lipid substrate.
PI3K enzymes are recruited to cellular membranes through interactions with phosphorylated tyrosine residues on receptor tyrosine kinases or adaptor proteins, or via direct binding to membrane lipids. For class I PI3Ks, the regulatory subunit (e.g., p85) binds to phosphotyrosine motifs, relieving inhibition of the catalytic subunit (e.g., p110) and localizing it to the membrane where its substrate phosphatidylinositol resides. Class II PI3Ks, such as PI3K C2α, have a distinct C2 domain that mediates membrane association and determines substrate specificity. Class III PI3K (Vps34) is recruited to endosomal membranes through interactions with Vps15 and other partners.
Catalytic phosphorylation of phosphatidylinositol
In simple terms: The enzyme transfers a phosphate from ATP onto the lipid, creating a signaling molecule.
Once positioned at the membrane, the catalytic subunit of PI3K transfers the gamma-phosphate of ATP to the D-3 position of the inositol ring of phosphatidylinositol, yielding phosphatidylinositol 3-phosphate (PI3P) and ADP. This reaction is highly regulated and can be reversed by phosphatases such as PTEN. The product PI3P serves as a docking site for proteins containing FYVE or PX domains, propagating downstream signals.
Generation of second messengers and downstream signaling
In simple terms: The lipid product acts as a flag to recruit other proteins that drive cell responses.
PI3P and other 3-phosphoinositides (e.g., PI(3,4,5)P3) act as second messengers that recruit pleckstrin homology (PH) domain-containing proteins such as AKT and PDK1 to the membrane. This leads to AKT phosphorylation and activation of mTOR, which in turn controls cell growth, proliferation, and survival. In autophagy, PI3P recruits proteins like WIPI2 and DFCP1 to initiate autophagosome formation. Thus, the catalytic activity of PI3K directly translates into diverse cellular outcomes.
Feedback regulation and termination
In simple terms: The signal is turned off by enzymes that remove the phosphate or degrade the lipid.
The activity of PI3K is counteracted by lipid phosphatases, most notably PTEN, which dephosphorylates PI(3,4,5)P3 to PI(4,5)P2, thereby terminating the signal. Additionally, SHIP phosphatases remove the 5-phosphate. Negative feedback loops involving mTORC1 and S6K also downregulate PI3K signaling. Dysregulation of these termination mechanisms, such as PTEN loss, leads to sustained PI3K activity and is common in cancer.
Key Genes Involved in GO:0016303 1-phosphatidylinositol-3-kinase activity
The following genes encode proteins that either possess 1-phosphatidylinositol-3-kinase activity or directly regulate it, and they are frequently studied in the context of GO:0016303.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIK3CA | Encodes the p110α catalytic subunit of class I PI3K | Frequently mutated in cancers; target for isoform-selective inhibitors |
| PIK3CB | Encodes the p110β catalytic subunit of class I PI3K | Implicated in PTEN-deficient tumors and metabolic signaling |
| PIK3CD | Encodes the p110δ catalytic subunit of class I PI3K | Key in immune cell signaling and hematological malignancies |
| PIK3CG | Encodes the p110γ catalytic subunit of class I PI3K | Drives noncanonical signaling in leukemia; potential drug target |
| PIK3C2A | Encodes class II PI3K C2α | Regulates endosomal trafficking and cell migration; structural studies reveal unique mechanism |
| PIK3C2B | Encodes class II PI3K C2β | Involved in insulin signaling and glucose transport |
| PIK3C3 | Encodes class III PI3K (Vps34) | Essential for autophagy initiation and endosomal sorting |
| PIK3R1 | Encodes the p85α regulatory subunit of class I PI3K | Mutations cause insulin resistance and cancer predisposition |
| PIK3R2 | Encodes the p85β regulatory subunit | Modulates PI3K activity in development and cancer |
| PTEN | Lipid phosphatase that opposes PI3K activity | Tumor suppressor; loss leads to hyperactive PI3K signaling |
| AKT1 | Serine/threonine kinase activated by PI3K products | Central downstream effector; oncogene in many cancers |
| MTOR | Kinase that integrates PI3K signals to control growth | Target of rapamycin analogs; key node in cancer and metabolism |
| IGF1 | Growth factor that activates PI3K via IGF1R | Regulates muscle atrophy and exercise adaptation |
| IGF1R | Receptor tyrosine kinase upstream of PI3K | Mediates IGF-1 signaling; target in cancer and metabolic disease |
| VPS15 | Regulatory subunit of class III PI3K | Required for Vps34 activity and autophagy |
| BECN1 | Component of the class III PI3K complex | Regulates autophagy initiation; tumor suppressor |
| UVRAG | Regulates class III PI3K complex in autophagy | Modulates autophagosome maturation and tumorigenesis |
How Is 1-phosphatidylinositol-3-kinase activity Regulated?
The activity of 1-phosphatidylinositol-3-kinase is tightly regulated at multiple levels. Class I PI3Ks are activated by receptor tyrosine kinases (RTKs) such as IGF1R, which phosphorylate adaptor proteins and recruit the p85 regulatory subunit, relieving inhibition of the p110 catalytic subunit. G-protein-coupled receptors can also activate PI3Kγ and PI3Kβ through direct binding of Gβγ subunits. Conversely, PTEN and SHIP phosphatases dephosphorylate 3-phosphoinositides to terminate signaling. Additionally, mTORC1 downstream of PI3K exerts negative feedback on RTKs, and class III PI3K is regulated by nutrient status and AMPK. In hepatic cells, class III PI3K promotes glucocorticoid receptor stability, linking PI3K activity to glucocorticoid signaling. These regulatory layers ensure that PI3K activity is transient and context-specific.
1-phosphatidylinositol-3-kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIK3CA | Breast, colon, endometrial cancer; activating mutations | Knock-in of hotspot mutations (e.g., H1047R) in cell lines; xenograft models |
| PIK3CG | Leukemia; noncanonical PI3Kγ signaling | Knockout or point-mutation in hematopoietic stem cells; patient-derived xenografts |
| PTEN | Cancer predisposition; loss leads to hyperactive PI3K | Knockout in cancer cell lines; conditional knockout mice |
| PIK3C3 | Autophagy defects; neurodegeneration | Knockout in neuronal cells; autophagy flux assays |
| PIK3R1 | Insulin resistance; metabolic syndrome | Knock-in of patient mutations in adipocytes or hepatocytes; glucose uptake assays |
PI3K activity in cancer
Dysregulated PI3K signaling is one of the most common oncogenic events. Activating mutations in PIK3CA (encoding p110α) occur frequently in breast, colon, and endometrial cancers, leading to constitutive lipid kinase activity and downstream AKT activation. In gastric cancer, the PI3K/AKT/mTOR pathway is often hyperactivated and correlates with poor prognosis. Noncanonical PI3Kγ signaling has been shown to support leukemia stem cell survival, and targeting this pathway with inhibitors represents a promising therapeutic approach. Additionally, inorganic pyrophosphatase 1 (PPA1) activates PI3K/Akt signaling to promote tumorigenicity and stemness in colorectal cancer. Thus, GO:0016303 is a central node in multiple malignancies.
PI3K activity in metabolic and muscle disorders
PI3K signaling mediates insulin action and glucose homeostasis. Mutations in PIK3R1 can cause insulin resistance and metabolic syndrome. In skeletal muscle, IGF-1/IGF-1R-PI3K/Akt signaling is critical for muscle hypertrophy, and aerobic and resistance exercise alleviate muscle atrophy through this pathway in myocardial infarction models. Therefore, modulating PI3K activity could have therapeutic potential for muscle-wasting conditions.
PI3K activity in autophagy and neurodegeneration
Class III PI3K (Vps34) generates PI3P, which is essential for autophagosome nucleation. Defects in autophagy contribute to neurodegeneration, and enhancing PI3K activity may be protective. Moreover, class III PI3K promotes hepatic glucocorticoid receptor stability, linking it to stress responses and metabolic regulation. These findings suggest that PI3K activity is relevant beyond cancer, impacting neuronal survival and metabolic stress.
From 1-phosphatidylinositol-3-kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PI3Kγ affect leukemia cell survival? | CRISPR knockout of PIK3CG in leukemia cell lines or primary cells |
| How do cancer-associated mutations in PIK3CA alter lipid kinase activity? | Point mutation knock-in (e.g., H1047R) in isogenic cell lines |
| What is the role of class III PI3K in autophagy? | Knockout of PIK3C3 in HeLa or MEF cells; LC3 flux analysis |
| Can overexpression of PIK3C2A rescue endosomal trafficking defects? | Overexpression of wild-type or mutant PIK3C2A in knockout background |
| Does IGF-1-induced PI3K activation require IGF1R? | Knockout of IGF1R in muscle cells; Western blot for p-AKT |
| How does PPA1 regulate PI3K/Akt signaling in colorectal cancer? | Knockout or overexpression of PPA1 in CRC cell lines; tumor sphere assays |
How to Study the 1-phosphatidylinositol-3-kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid kinase assay | Enzymatic activity of PI3K | In vitro validation of inhibitors or mutants |
| Western blot for p-AKT | Downstream activation of PI3K pathway | Assessing pathway inhibition or genetic perturbation |
| PI3P biosensor imaging | Subcellular localization of PI3P | Studying autophagy and endosomal dynamics |
| CRISPR knockout screen | Genes required for PI3K-driven phenotypes | Identifying synthetic lethal targets |
| RNA-seq | Transcriptional changes upon PI3K modulation | Uncovering downstream gene expression programs |
| Proteomics | Protein interactions and post-translational modifications | Mapping PI3K signaling complexes |
| Autophagy flux assay | Autophagosome formation and degradation | Evaluating class III PI3K function |
| Glucose uptake assay | Metabolic effect of PI3K activation | Studying insulin resistance |
Lipid kinase assays
In vitro lipid kinase assays using recombinant PI3K enzymes or immunoprecipitates from cell lysates are the gold standard to measure 1-phosphatidylinositol-3-kinase activity. These assays typically use phosphatidylinositol as substrate and [γ-32P]ATP, followed by thin-layer chromatography to separate radiolabeled PI3P. Alternatively, fluorescence-based or ADP-Glo assays can be used for high-throughput screening.
Phospho-specific antibodies and Western blotting
Activation of PI3K signaling can be monitored by Western blot using antibodies against phosphorylated AKT (p-AKT S473 and T308), which are downstream readouts of PI3K activity. This method is widely used to assess pathway inhibition or genetic manipulation.
Live-cell imaging of PI3P
Genetically encoded biosensors, such as GFP-tagged FYVE or PX domains that bind PI3P, allow real-time visualization of PI3K product distribution in living cells. This technique is valuable for studying membrane trafficking and autophagy dynamics.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate PI3K activity or its downstream effects. For example, screens in cancer cell lines treated with PI3K inhibitors can reveal resistance mechanisms. These approaches are complemented by RNA-seq and proteomics to dissect transcriptional and signaling networks.
How CRISPR Can Be Used to Study GO:0016303 1-phosphatidylinositol-3-kinase activity
Knockout
CRISPR knockout of PI3K genes (e.g., PIK3CA, PIK3CG, PIK3C3) is used to completely abolish specific isoform activity, enabling researchers to study loss-of-function phenotypes. For example, knockout of PIK3CG in leukemia cells demonstrated a dependency on noncanonical PI3Kγ signaling. Knockout of PIK3C3 impairs autophagy and endosomal trafficking. These models are essential for target validation.
Point Mutation
Point mutation knock-in via CRISPR allows the introduction of disease-associated mutations, such as PIK3CA H1047R or E545K, into the endogenous locus. This creates isogenic cell lines that mimic cancer-specific activation of PI3K, providing a platform to test isoform-selective inhibitors and study downstream signaling.
Knock-in
Knock-in of epitope tags (e.g., HA, GFP) or fluorescent reporters into PI3K genes enables real-time tracking of protein localization and interaction. Tagged knock-in of PIK3C2A can reveal its dynamic recruitment to endosomes. Additionally, knock-in of inducible degron tags allows rapid depletion of PI3K proteins to study acute effects.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of wild-type or mutant PI3K genes is used to gain insight into gain-of-function effects. Overexpression of PIK3C2A or PIK3CA can drive oncogenic transformation and is useful for studying pathway hyperactivation. These models complement knockout studies.
How EDITGENE Supports 1-phosphatidylinositol-3-kinase activity Research
Researchers studying 1-phosphatidylinositol-3-kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of PI3K isoforms and their regulators.
Contact EDITGENE today to design your custom CRISPR model for 1-phosphatidylinositol-3-kinase activity research.
Frequently Asked Questions About 1-phosphatidylinositol-3-kinase activity
What is 1-phosphatidylinositol-3-kinase activity?
It is the enzymatic activity that adds a phosphate group to the third position of the inositol ring of phosphatidylinositol, producing phosphatidylinositol 3-phosphate and ADP. This activity is encoded by GO:0016303 and is carried out by PI3K enzymes.
What genes are involved in 1-phosphatidylinositol-3-kinase activity?
The main genes include PIK3CA, PIK3CB, PIK3CD, PIK3CG (class I), PIK3C2A, PIK3C2B (class II), and PIK3C3 (class III), as well as regulatory subunits like PIK3R1 and PIK3R2.
What is the difference between class I, II, and III PI3K?
Class I PI3Ks are activated by receptors and produce PI(3,4,5)P3; class II PI3Ks produce PI3P and PI(3,4)P2 and are involved in trafficking; class III PI3K (Vps34) produces PI3P and is essential for autophagy.
How is PI3K activity measured?
Common methods include in vitro lipid kinase assays with radiolabeled ATP, Western blot for phosphorylated AKT, and live-cell imaging with PI3P biosensors.
What diseases are associated with PI3K activity?
Dysregulated PI3K activity is linked to many cancers (e.g., breast, colon, leukemia), insulin resistance, and autophagy-related disorders.
Can CRISPR be used to study PI3K genes?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are widely used to dissect the specific roles of PI3K isoforms in cells and animal models.
What is the role of class III PI3K in autophagy?
Class III PI3K (Vps34) generates PI3P, which recruits autophagy-related proteins to initiate autophagosome formation.
How does PTEN regulate PI3K activity?
PTEN is a lipid phosphatase that dephosphorylates PI(3,4,5)P3 to PI(4,5)P2, thereby opposing PI3K signaling and acting as a tumor suppressor.
What are the therapeutic implications of targeting PI3K?
PI3K inhibitors are in clinical trials for cancer, and isoform-selective inhibitors may reduce toxicity. Targeting noncanonical PI3Kγ has shown promise in leukemia.
How does exercise affect PI3K activity in muscle?
Exercise can activate IGF-1/IGF-1R-PI3K/Akt signaling, which helps alleviate muscle atrophy in conditions like myocardial infarction.
Conclusion
1-phosphatidylinositol-3-kinase activity (GO:0016303) is a fundamental enzymatic function that governs cell growth, survival, metabolism, and autophagy through the generation of 3-phosphoinositides. Its dysregulation is central to cancer, metabolic disorders, and neurodegenerative conditions, making it a prime target for therapeutic intervention. Advances in CRISPR-based genome editing have revolutionized the study of PI3K isoforms, enabling precise knockout, point mutation, and knock-in models that reveal isoform-specific functions and disease mechanisms. As research continues to uncover the complexities of PI3K signaling, tools for precise genetic manipulation will be indispensable for translating these insights into clinical applications.
References
- 1. Luo Q et al.. 2024. Targetable leukaemia dependency on noncanonical PI3Kγ signalling.. Nature 630(8015):198-205 PMID: 38720074
- 2. Morgos DT et al.. 2024. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.. Int J Mol Sci 25(3) PMID: 38339127
- 3. Niu T et al.. 2023. Inorganic pyrophosphatase 1 activates the phosphatidylinositol 3-kinase/Akt signaling to promote tumorigenicity and stemness properties in colorectal cancer.. Cell Signal 108:110693 PMID: 37141926
- 4. Thiel G et al.. 2021. Insulin-Responsive Transcription Factors.. Biomolecules 11(12) PMID: 34944530
- 5. Feng L et al.. 2022. Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt pathway in mice with myocardial infarction.. Am J Physiol Cell Physiol 322(2):C164-C176 PMID: 34852207
- 6. Hurley JH et al.. 2017. Mechanisms of Autophagy Initiation.. Annu Rev Biochem 86:225-244 PMID: 28301741
- 7. Shibayama Y et al.. 2022. Class 3 phosphoinositide 3-kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity.. Acta Physiol (Oxf) 235(1):e13793 PMID: 35094500
- 8. Lo WT et al.. 2022. Structural basis of phosphatidylinositol 3-kinase C2α function.. Nat Struct Mol Biol 29(3):218-228 PMID: 35256802
